Price (delayed)
$94.2
Market cap
$14.92B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$7.69
Enterprise value
$16.34B
Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a
There are no recent dividends present for ILMN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.